Posts

Breakthrough may clear major hurdle for quantum computers

The potential of quantum computers is currently thwarted by a trade-off problem....

Insilico Medicine nominates the winner of documentary h...

After receiving more than 90 submissions from 14 countries with a wide range of ...

Cosmic blast hunter SVOM to launch with optimal optics ...

A satellite telescope designed to rapidly hunt down the universe’s biggest explo...

Interdisciplinary team at MUSC Hollings Cancer Center m...

A new paper from an interdisciplinary team at MUSC Hollings Cancer Center descri...

IISc physicists find a new way to represent ‘pi’

While investigating how string theory can be used to explain certain physical ph...

Researchers uncover mechanism that fuels growth of aggr...

Researchers from the University of Helsinki and HUS investigated the effects of ...

LMU researchers film energy materials as they form

Shooting a movie in the lab requires special equipment. Especially when the acto...

Salk scientist Jesse Dixon named 2024 Pew Biomedical Sc...

LA JOLLA (June 18, 2024)—Salk Institute Assistant Professor Jesse Dixon has been...

Study forecasts 110,000 premature deaths by 2050 due to...

A new study from the Pohang University of Science and Technology (POSTECH) indic...

Odors are encoded in rings in the brain of migratory lo...

The migratory locust Locusta migratoria is an economically important crop pest t...

Advanced artificial intelligence: a revolution for sust...

The rise of advanced artificial intelligence (edge AI) could well mark the begin...

Small Molecule to Target PSMA for Metastatic Hormone Re...

Small Molecule to Target PSMA for Metastatic Hormone Refractory Prostate Cancer ...

MEDI-0618 by AstraZeneca for Migraine: Likelihood of Ap...

MEDI-0618 is under clinical development by AstraZeneca and currently in Phase I ...

DFV-890 by Novartis for Coronary Artery Disease (CAD) (...

DFV-890 is under clinical development by Novartis and currently in Phase II for ...

OCT-461201 by Oxford Cannabinoid Technologies for Neuro...

OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...

OCT-461201 by Oxford Cannabinoid Technologies for Visce...

OCT-461201 is under clinical development by Oxford Cannabinoid Technologies and ...